Ron Cohen - Nov 12, 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC (ACOR)

Role
President and CEO, Director
Signature
/s/ Ron Cohen
Stock symbol
ACOR
Transactions as of
Nov 12, 2021
Transactions value $
$0
Form type
4
Date filed
11/15/2021, 03:34 PM
Previous filing
Sep 8, 2021
Next filing
Mar 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Employee Stock Option (right to buy) Award $0 +100K $0.00 100K Nov 12, 2021 Common Stock 100K $3.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to these options vest in equal quarterly installments over four years beginning on November 12, 2021, with the first quarterly installment vesting on February 12, 2022.